Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats

Eur J Pharmacol. 2016 Nov 15:791:25-36. doi: 10.1016/j.ejphar.2016.08.017. Epub 2016 Aug 24.

Abstract

This study shows that in spontaneously hypertensive rats (SHR) of 14-weeks-old, the sympathetically-induced, but not noradrenaline-induced tachycardic response are higher than age-matched Wistar normotensive rats. Furthermore, in SHR the sympathetically-induced tachycardic response was: (1) unaffected by moxonidine (3μg/kgmin); (2) partially inhibited by B-HT 933 (30μg/kgmin), both at the lowest doses; and (3) completely inhibited by the highest doses of B-HT 933 (100μg/kgmin), moxonidine (10μg/kgmin) or agmatine (1000 and 3000μg/kgmin) while the noradrenaline-induced tachycardic responses remained unaffected by the above compounds, except by 3000μg/kgmin agmatine. In SHR, 300μg/kg rauwolscine failed to block the sympatho-inhibition to 100μg/kgmin B-HT 933 or 10μg/kgmin moxonidine, but 1000μg/kg rauwolscine abolished, partially antagonized, and did not modify the sympatho-inhibition to the highest doses of B-HT 933, moxonidine, and agmatine, respectively, 3000μg/kg AGN 192403 or 300μg/kg BU224 given alone had no effect in the moxonidine- or agmatine-induced sympatho-inhibition, and the combination rauwolscine plus AGN 192403 but not plus BU224, abolished the sympatho-inhibition to the highest doses of moxonidine and agmatine. In conclusion, the sympathetically-induced tachycardic responses in SHR are inhibited by moxonidine and agmatine. The inhibition of moxonidine is mainly mediated by prejunctional α2-adrenoceptors and to a lesser extent by I1-imidazoline receptors, while the inhibition of agmatine is mediated by prejunctional α2-adrenoceptors and I1-imidazoline receptors at the same extent. Notwithstanding, the inhibitory function of α2-adrenoceptors seems to be altered in SHR compared with Wistar normotensive rats.

Keywords: (±)-noradrenaline bitartrate salt (PubChem CID: 5813); AGN 192403 hydrochloride (PubChem CID: 11957452); Agmatine; Agmatine sulfate salt (PubChem CID: 2794990); B-HT 933 dihydrochloride (PubChem CID: 169743); BU224 hydrochloride (PubChem CID: 11957470); Hypertension; I(1)-imidazoline receptor; Moxonidine; desipramine hydrochloride (PubChem CID: 65327); gallamine triethiodide (PubChem CID: 6172); moxonidine hydrochloride (PubChem CID: 11231255); rauwolscine hydrochloride (PubChem CID: 197067); α(2)-adrenoceptor.

MeSH terms

  • Agmatine / pharmacology*
  • Animals
  • Bridged Bicyclo Compounds / pharmacology
  • Heart / drug effects*
  • Heart / innervation*
  • Heart / physiopathology
  • Heart Rate / drug effects
  • Hemodynamics / drug effects
  • Heptanes / pharmacology
  • Imidazoles / pharmacology*
  • Male
  • Norepinephrine / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar
  • Sympathetic Nervous System / drug effects*
  • Sympathetic Nervous System / physiopathology
  • Yohimbine / pharmacology

Substances

  • AGN 192403
  • BU 224
  • Bridged Bicyclo Compounds
  • Heptanes
  • Imidazoles
  • Yohimbine
  • Agmatine
  • moxonidine
  • Norepinephrine